Thanks for your input. I don't know what the fuss is about earnings anyway. EArly biotech earnings are irrelevant . It would appear the stock ran into earnings for some reason, but maybe that was a coincidence. And to sell on earnings? weirder...
There's always the much bigger picture to consider. Or else why would AGIX be trading where it is.